Drug intelligence / Profile preview

IQANNA

Development stage
Unknown
Lead developer
Clever Leaves
Modality
Small Molecules
01

Overview

IQANNA is a brand of medical cannabis products, including dried flower and extracts, developed and supplied by Clever Leaves. These products are produced in Clever Leaves' GACP-certified and GMP-certified facilities in Portugal and Colombia and are distributed in international markets, notably Germany, through partnerships with companies like Ethypharm. The IQANNA brand encompasses various chemovars of *Cannabis sativa*, containing active cannabinoids such as delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These cannabinoids interact with the human endocannabinoid system, primarily targeting CB1 and CB2 receptors to provide therapeutic effects. In Germany, these products are prescribed for a variety of conditions, including chronic pain, spasticity associated with multiple sclerosis, and chemotherapy-induced nausea, particularly when conventional treatments have proven insufficient.

Brand names
IQANNA
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on IQANNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IQANNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call